The American College of Rheumatology developed guidance for the management of pediatric patients with multisystem inflammatory syndrome associated with COVID-19.
COVID-19 has brought unprecedented stress to society at large and perhaps most of all to frontline healthcare teams in a variety of settings. We spoke to an expert about teamwork during such trying times.
Recent studies have led to important insights regarding the role of viruses in asthma pathogenesis and exacerbations, as well as mediating factors involved in these processes.
Examining the gut microbiome for biomarkers that may aid in the detection of pre-cancerous adenomas and/or CRC has significant utility in both research and real world settings.
Study leads Shilpa Venkatachalam, MD, and Michael George, MD, discuss the highlights of a new initiative to track the effects of COVID-19 in autoimmune disorders.
In-hospital use of continuous glucose monitoring may offer improvements in glycemic control and reduced exposure to COVID-19 for healthcare professionals.
There are increasing data to support that many patients with COVID-19 can develop a myriad of gastrointestinal symptoms, which include mild diarrhea, nausea, vomiting and abdominal pain.
Growing concerns about thromboembolic comorbidities in patients with COVID-19 is leading ASH to create clinical practice guidelines to treat this patient population.
Due to innate and adaptive immune alterations and the risk for nosocomial infection from exposure to potentially infected blood-borne sources, patients with end-stage renal disease (ESRD) have an elevated risk of contracting viral infections.
It is certainly too early to know if there will be any seasonal variation to SARS-CoV-2 infection, and there is no reason to specifically compare this virus with the seasonal behavior of influenza virus or to other seasonal respiratory viruses.
Mitigating the spread of a virus as infectious as SARS-CoV-2 requires having ample and accurate diagnostic tests available. However, in the United States, community transmission began to occur before adequate testing measures could be implemented.
Progression in characterizing the symptoms and treatments for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent development of coronavirus disease 2019 (COVID-19).
The use of telemedicine has been surging since the onset of coronavirus disease 2019 (COVID-19), with millions of Americans now using this medium for connecting with their clinicians.
Specialists emphasized that although shared ventilation may be necessary in times of crisis, innovative alternatives should be used to avoid such extreme measures during the COVID-19 pandemic.
Although influenza virus and respiratory syncytial virus are considered to be spread by droplets and aerosol transmission, the mode of respiratory transmission of SARS-CoV-2 is not completely understood.
Hydroxychloroquine is a less-toxic metabolite of the antimalarial drug chloroquine and is used as an immunomodulator for the treatment of autoimmune diseases.
